Key Takeaways
- • Blackstone announced the final close of Blackstone European Senior Direct Lending Fund IV (BXDE IV), and said the firm has closed on about €13 billion of investable capital across BXDE IV and other European direct lending vehicles, including anticipated leverage, since the fund's launch.
- • The November 4 statement positioned the raise as evidence of strong investor demand for European private credit, with BXDE IV targeting high-quality European borrowers in the middle and upper middle market.
- • Since launch, Blackstone has taken lead-lender roles in Angelini Pharma's take-private of Catalyst Pharmaceuticals (€1.0 billion), Regnology (€780 million), Odevo (€649 million) and JTC (€382 million).
- • Blackstone frames the close as part of a longer-term thesis to invest more than $500 billion of assets in Europe by 2035, with credit a significant component.
- • Blackstone Credit & Insurance employs more than 100 investment professionals across five European offices in London, Dublin, Frankfurt, Milan and Paris.
Summary
Blackstone announced the final close of Blackstone European Senior Direct Lending Fund IV, or BXDE IV, according to a November 4 statement reported by HedgeCo.Net. The firm said that across BXDE IV and other European direct lending vehicles, including anticipated leverage, it has closed on about €13 billion of investable capital since the fund's launch. Blackstone presented the raise as evidence of strong investor demand for European private credit. For allocators, the relevant figure is investable capital including anticipated leverage across the European direct lending complex rather than a single fund's AUM.
BXDE IV targets high-quality European borrowers across the size spectrum, with a focus on the middle and upper middle market. Since the fund's launch, Blackstone said it has committed significant capital across European private credit, including lead-lender roles in Angelini Pharma's take-private of Catalyst Pharmaceuticals (€1.0 billion), Regnology (€780 million), Odevo (€649 million) and JTC (€382 million). The firm cites more than two decades of credit investing in Europe spanning direct lending, infrastructure and asset-based credit, and CLOs.
Blackstone Credit & Insurance now has more than 100 investment professionals across five European offices in London, Dublin, Frankfurt, Milan and Paris. Brad Marshall, global head of private credit strategies, said the fundraise reflects investor confidence in private credit and the firm's ability to deliver scaled financing across market cycles. Mike Carruthers, European head of private credit strategies, said Europe remains one of the most attractive private credit markets globally, with borrowers valuing certainty, scale and flexibility.
The close sits within a longer-term deployment thesis. Blackstone sees credit as a significant part of the opportunity to invest more than $500 billion of assets in Europe by 2035. Open diligence questions for investors include pacing relative to the deal pipeline already disclosed, concentration in upper middle-market sponsor finance, and how the five-office European platform competes on certainty and speed against other scaled direct lenders.
BXDE IV targets high-quality European borrowers across the size spectrum, with a focus on the middle and upper middle market. Since the fund's launch, Blackstone said it has committed significant capital across European private credit, including lead-lender roles in Angelini Pharma's take-private of Catalyst Pharmaceuticals (€1.0 billion), Regnology (€780 million), Odevo (€649 million) and JTC (€382 million). The firm cites more than two decades of credit investing in Europe spanning direct lending, infrastructure and asset-based credit, and CLOs.
Blackstone Credit & Insurance now has more than 100 investment professionals across five European offices in London, Dublin, Frankfurt, Milan and Paris. Brad Marshall, global head of private credit strategies, said the fundraise reflects investor confidence in private credit and the firm's ability to deliver scaled financing across market cycles. Mike Carruthers, European head of private credit strategies, said Europe remains one of the most attractive private credit markets globally, with borrowers valuing certainty, scale and flexibility.
The close sits within a longer-term deployment thesis. Blackstone sees credit as a significant part of the opportunity to invest more than $500 billion of assets in Europe by 2035. Open diligence questions for investors include pacing relative to the deal pipeline already disclosed, concentration in upper middle-market sponsor finance, and how the five-office European platform competes on certainty and speed against other scaled direct lenders.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.